Yale researchers have identified a protein that drives symptoms of severe liver disease and may be a target for treatment in the future. A severe form of fatty liver disease called nonalcoholic steatohepatitis (NASH) is the leading cause of liver transplantation, but there are few treatment options and currently no medications.

People who have experienced symptoms for months or longer after being infected exhibit different immune and hormonal responses to the virus, a new study finds.

Increased tagging of fish, seals, birds, and other animals can help fill key data gaps in understanding the world's changing climate, Yale scientists say.

A new study finds medical students from marginalized backgrounds are less likely to pursue surgical careers, affecting workforce diversity and patient care.

Two distinct abnormalities that arise just weeks after the start of brain development have been associated with the emergence of autism spectrum disorder. Two distinct neurodevelopmental abnormalities that arise just weeks after the start of brain development have been associated with the emergence of autism spectrum disorder, according to a new Yale-led study in which researchers developed brain organoids from the stem cells of boys diagnosed with the disorder.

The new model will help scientists find human-specific mechanisms for regulating cholesterol levels and potentially for treating chronic liver diseases. Yale researchers have created a functional -humanized- liver in living mice that will help scientists find human-specific mechanisms for regulating cholesterol levels and potentially for treating chronic liver diseases afflicting tens of millions of people in the United States.

A new Yale study proposes a way that collisions between asteroids might lead to the formation of metal asteroids able to generate and record magnetism.

Yale researchers have identified a protein that drives symptoms of severe liver disease and may be a target for treatment in the future. A severe form of fatty liver disease called nonalcoholic steatohepatitis (NASH) is the leading cause of liver transplantation, but there are few treatment options and currently no medications.

Yale researchers show that placental examination could help determine the cause of more than 90% of previously unexplained pregnancy losses.

Air pollution has decreased across the U.S., but new research finds health burdens remain unequal among racial groups. Health benefits that have resulted from reductions in fine particulate air pollution aren-t distributed equally among populations in the U.S., a new Yale-led study finds.

New Yale research finds nearly 30% of emergency department patients are jumped in line, and marginalized groups bear the brunt. In most U.S. emergency departments (ED), patients are admitted in an order based on both the urgency of their condition and when they arrived.

The new model will help scientists find human-specific mechanisms for regulating cholesterol levels and potentially for treating chronic liver diseases. Yale researchers have created a functional -humanized- liver in living mice that will help scientists find human-specific mechanisms for regulating cholesterol levels and potentially for treating chronic liver diseases afflicting tens of millions of people in the United States.

How a person's immune system interacts with tumor cells influences how cancer progresses and can explain why treatment causes tumors to shrink for some patients but not others. Yale researchers have developed a new method to better understand these complex interactions, recreating patients- specific tumor microenvironments in mice for more in-depth and individualized study.

A new study finds M.D.-Ph.D. program attrition is highest among Black students, which has impacts on the diversity and innovation of biomedicine. Black M.D.-Ph.D. students are 83% more likely than white students to leave medical school and 50% more likely to graduate with only an M.D., according to a new Yale-led study.